Who owns APREA THERAPEUTICS INC?
- Ticker: APRE
- CUSIP Number: 03836j201
Tip: Access positions for across all investors
Analyze quarterly positions in Aprea Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aprea Therapeutics stock
Who bought or sold APREA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AIGH Capital Management | 371k | $316k | -31% | Dec 2025 |
|
| Murchinson | 340k | $290k | 100% | Dec 2025 |
|
| Sphera Funds Management | 270k | $230k | 0% | Dec 2025 |
|
| Nantahala Capital Management | 206k | $176k | 0% | Dec 2025 |
|
| DRW Holdings | 121k | $103k | 100% | Dec 2025 |
|
| Sio Capital Management | 112k | $166k | -60% | Sep 2025 |
|
| Vanguard Group | 58k | $50k | -63% | Dec 2025 |
|
| Jane Street | 47k | $40k | 100% | Dec 2025 |
|
| Geode Capital Management | 41k | $35k | -8% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 27k | $23k | 60% | Dec 2025 |
|
| LPL Financial | 26k | $22k | 62% | Dec 2025 |
|
| XTX Topco | 24k | $21k | 100% | Dec 2025 |
|
| HighTower Advisors | 14k | $12k | 0% | Dec 2025 |
|
| BlackRock | 8.5k | $7.3k | 0% | Dec 2025 |
|
| Tower Research Capital | 7.8k | $6.7k | 1278% | Dec 2025 |
|
| UBS Group | 2.5k | $2.5k | 81933% | Dec 2025 |
|
| Group One Trading | 577.00 | $492.007900 | 0% | Dec 2025 |
|
| Advisor Group Holdings | 300.00 | $255.000000 | -25% | Dec 2025 |
|
| WealthCollab | 158.00 | $134.995200 | 0% | Dec 2025 |
|
| SBI Securities | 15.00 | $13.000500 | -64% | Dec 2025 |
|
Who sold out of Aprea Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DAFNA Capital Management | Sep 2025 | 137k | $202k |
| Hrt Financial | Sep 2025 | 12k | $18k |
| Landscape Capital Management | Sep 2025 | 11k | $16k |
| Mb, Levis & Associates | Sep 2025 | 806.00 | $1.2k |
| FMR | Jun 2025 | 501.00 | $852.000600 |